Eric Liu Md Aiq Global Dr. eric liu is a board certified general surgeon with advanced sub specialty expertise in neuroendocrine cancers. he is a recognized leader in multi modal treatment of neuroendocrine tumors and, specifically, in the use of theranostics. More than 20 years experience in clinical management and cancer center operations. led multiple tech companies from founding to exit, including acquisitions and an ipo. experience in us, australia, and europe. former global general manager for $220m business at ge healthcare. second time start up ceo.
Eric Liu Scientific Advisor At Aiq Solutions The Org Dr. eric liu is a board certified general surgeon with advanced sub specialty expertise in neuroendocrine cancers. he is a recognized leader in multi modal treatment of neuroendocrine tumors and, specifically, in the use of theranostics. Dr. eric liu is a board certified general surgeon with advanced sub specialty expertise in neuroendocrine cancers. he is a recognized leader in multi modal treatment of neuroendocrine tumors and, specifically, in the use of theranostics. Aiq solutions is a group of passionate entrepreneurs, scientists, and engineers with a vision to improve treatment outcomes for patients with a wide range of complex diseases, all around the world. leveraging a strong foundation of intellectual property, aiq is continuously innovating. Dr. liu has published over 100 manuscripts and book chapters, and has expertise in all phases of clinical trials, biomarker development, and use of molecular imaging in therapy development. he is co founder of aiq solutions, and currently serves as its chief medical officer.
Aiq Global Aiq solutions is a group of passionate entrepreneurs, scientists, and engineers with a vision to improve treatment outcomes for patients with a wide range of complex diseases, all around the world. leveraging a strong foundation of intellectual property, aiq is continuously innovating. Dr. liu has published over 100 manuscripts and book chapters, and has expertise in all phases of clinical trials, biomarker development, and use of molecular imaging in therapy development. he is co founder of aiq solutions, and currently serves as its chief medical officer. Robert covered the science behind aiq’s products, explaining how quantitative imaging biomarkers can be combined with ai to provide unique intelligence on treatment response. Aiq solutions (also known as aiq global) is a medical device technology company that develops software and services for cancer treatment response management. its platform is designed to manage therapy and tracer development services for pharma and radio pharma companies. Aiq solutions develops a medical device technology platform that revolutionizes the treatment response of patients with complex diseases. Please use the form below for questions.
Aiq Global Robert covered the science behind aiq’s products, explaining how quantitative imaging biomarkers can be combined with ai to provide unique intelligence on treatment response. Aiq solutions (also known as aiq global) is a medical device technology company that develops software and services for cancer treatment response management. its platform is designed to manage therapy and tracer development services for pharma and radio pharma companies. Aiq solutions develops a medical device technology platform that revolutionizes the treatment response of patients with complex diseases. Please use the form below for questions.
Aiq Global Aiq solutions develops a medical device technology platform that revolutionizes the treatment response of patients with complex diseases. Please use the form below for questions.
Aiq Global
Comments are closed.